Effects of Abatacept in patients with rheumatoid arthritis and cancer risk

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 112

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RCM-10-4_004

تاریخ نمایه سازی: 13 اسفند 1402

چکیده مقاله:

Introduction: As a chronic autoimmune disease, Rheumatoid arthritis (RA) affects the joints. Studies have shown a complex and challenging link between cancer and RA. However, articles claim a significant relationship between cancer and treatment with DMARDs and biological DMARDs (e.g., Abatacept); however, the results are contradictory. Accordingly, this systematic review investigates the prevalence of cancer in RA patients taking Abatacept.Methods: We searched for articles published in four databases, namely Web of Science, Medline, PubMed, and Scopus up to September ۲۹, ۲۰۲۳. The methodology followed recommendations from the Cochrane Handbook. During the search process, we selected articles using keywords such as “rheumatoid arthritis”, “malignancy”, and “cancer” with the Boolean operators “AND” and “OR”.”Results: A total of ۱۲ studies were considered, the majority highlighted the effectiveness of Abatacept as an anti-RA medicine in the risk of cancer prevalence. Most of the patients investigated in the trials were female. Lung cancer was the greatest malignancy in those suffering from RA diseases. However, these investigations found no significant link between Abatacept use and cancer risk.Conclusion: There is speculation regarding the potential use of rheumatoid arthritis drugs in treating RA and its potential association with cancer incidence. According to the findings presented in this review article, there was no statistically significant association between the utilization of Abatacept and the prevalence of cancer in patients who were administered Abatacept either as a standalone treatment or in combination with other anti-rheumatoid medications. However, it is advised that further clinical trials be conducted to thoroughly investigate this association.

نویسندگان

Saba Homapoor

Resident of Internal Medicine, Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Sahebari

Professor of Rheumatology, Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Mandana Khodashahi

Associate Professor of Rheumatology, Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Pundole X, Suarez-Almazor ME. Cancer and rheumatoid arthritis. Rheumatic Disease ...
  • Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, ...
  • Kim G, Barner JC, Rascati K, Richards K. Factors associated ...
  • Shimaoka H, Takeno S, Maki K, Sasaki T, Hasegawa S, ...
  • Ekström K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, ...
  • Chen YJ, Chang YT, Wang CB, Wu CY. The risk ...
  • Hemminki K, Li X, Sundquist K, Sundquist J. Cancer risk ...
  • Parikh-Patel A, White RH, Allen M, Cress R. Risk of ...
  • Lim XR, Xiang W, Tan JWL, Koh LW, Lian TY, ...
  • Carmona L, Descalzo MA, Perez-Pampin E, Ruiz- Montesinos D, Erra ...
  • Yang D, Krasnova A, Nead K, Choueiri T, Hu J, ...
  • Montastruc F, Renoux C, Dell’Aniello S, Simon TA, Azoulay L, ...
  • Chatzidionysiou K, Delcoigne B, Frisell T, Hetland ML, Glintborg B, ...
  • Pombo-Suarez M, Gomez-Reino JJ. Abatacept for the treatment of rheumatoid ...
  • Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, ...
  • Solomon DH, Kremer JM, Fisher M, Curtis JR, Furer V, ...
  • Administration FaD. FDA Drug Safety Communication: UPDATE on Tumor Necrosis ...
  • Julian Higgins۱ JT. Cochrane Handbook for Systematic Reviews of Interventions ...
  • Wadström H, Frisell T, Askling J, Anti-Rheumatic Therapy in Sweden ...
  • de Germay S, Bagheri H, Despas F, Rousseau V, Montastruc ...
  • Kim SC, Schneeweiss S, Liu J, Karlson EW, Katz JN, ...
  • Simon TA, Boers M, Hochberg M, Baker N, Skovron ML, ...
  • Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. ...
  • Alten R, Kaine J, Keystone E, Nash P, Delaet I, ...
  • Kim SC, Pawar A, Desai RJ, Solomon DH, Gale S, ...
  • Wang S-D, Li H-Y, Li B-H, Xie T, Zhu T, ...
  • Hu P, Liu Q, Deng G, Zhang J, Liang N, ...
  • Herrero-Beaumont G, Calatrava MJM, Castañeda S. Abatacept mechanism of action: ...
  • Hashimoto A, Chiba N, Tsuno H, Komiya A, Furukawa H, ...
  • Simon T, Smitten A, Franklin J, Askling J, Lacaille D, ...
  • Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, ...
  • Huss V, Bower H, Wadström H, Frisell T, Askling J. ...
  • Ko KM, Moon S-J. Prevalence, incidence, and risk factors of ...
  • Simon TA, Suissa S, Boers M, Hochberg MC, Skovron ML, ...
  • Kunishita Y, Ichikawa K, Uzawa Y, Mitsuhashi M, Yoshioka Y, ...
  • نمایش کامل مراجع